Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.2100 (-1.2%) ($8.2100 - $8.2100) on Tue. Jun. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 39 | Latest Price | $8.2100(-1.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SDY(26%) BND(25%) XLRE(25%) VYM(23%) ARKG(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.36% in a week (0% probabilities). VIXM(-27%) VXX(-23%) TLT(-18%) VCIT(-17%) SHY(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.39 | 5 Day Moving Average | $8.54(-3.86%) | 10 Day Moving Average | $8.46(-2.96%) | 20 Day Moving Average | $8.39(-2.15%) | To recent high | -7.3% | To recent low | 11.3% | Market Cap | $1.448b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |